What is Myos Rens Technology Forward Dividend Yield %?
As of today (2024-05-05), the Forward Annual Dividend Yield of Myos Rens Technology is 0.00%.
As of today (2024-05-05), the Trailing Annual Dividend Yield of Myos Rens Technology is 0.00%.
MYOS's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.82 * Ranked among companies with meaningful Forward Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison of Myos Rens Technology's Forward Dividend Yield %
For the Drug Manufacturers - Specialty & Generic subindustry, Myos Rens Technology's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Myos Rens Technology's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Myos Rens Technology's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Myos Rens Technology's Forward Dividend Yield % falls into.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Myos Rens Technology Forward Dividend Yield % Related Terms
Thank you for viewing the detailed overview of Myos Rens Technology's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Myos Rens Technology (Myos Rens Technology) Business Description
Myos Rens Technology Inc is a US-based bio-nutrition and biotherapeutics company. It focuses on the discovery, development, and commercialization of products that improve muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases. The company develops nutritional and therapeutic products for maintaining and improving the health and performance of muscle tissue. Its research is focused on developing strategies and therapeutic interventions to address muscle related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases such as Sarcopenia, Cachexia, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MYOS has been successfully added to your